Caliper Life Sciences to Acquire NovaScreen Biosciences for Up to $30M in Stock and Cash | GenomeWeb

NEW YORK, Sept. 8 (GenomeWeb News) - Caliper Life Sciences plans to acquire NovaScreen Biosciences, a screening, profiling, and assay development-services company for up to $30 million in stock and cash, Caliper said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.